Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Monteleone

Showing results (11-20 of 384) with videos related to

Pageof 39
Sort By:
Inflammatory Bowel Diseases|February 1, 2023
Reply: Frail Phenotype in Patients With Inflammatory Bowel DiseaseSilvia Salvatori, Giovanni Monteleone
Expert Opinion on Drug Safety|June 14, 2017
The safety of non-biological treatments in Ulcerative ColitisEdoardo Troncone, Giovanni Monteleone
United European Gastroenterology Journal|December 29, 2023
Gut microbiota analysis in inflammatory bowel disease: Novel findings from old dataIrene Marafini, Giovanni Monteleone
Annals of Medicine|June 19, 2018
Inflammatory bowel disease: new therapies from antisense oligonucleotidesIrene Marafini, Giovanni Monteleone
Surgical Neurology International|November 19, 2016
Entrapment of the sciatic nerve at the linea aspera: A case report and literature reviewGiovanni Monteleone, Giorgio Stevanato
Inflammatory Bowel Diseases|September 26, 2008
Why are molecular mechanisms of immune activation important in IBD?Giovanni Monteleone, Flavio Caprioli
Expert Review of Gastroenterology & Hepatology|July 20, 2018
Advances in understanding the role of cytokines in inflammatory bowel diseaseGerolamo Bevivino, Giovanni Monteleone
Gastroenterology|August 31, 2015
Reply: To PMID 25785968Giovanni Monteleone, Francesco Pallone
Cancers|May 5, 2019
Smad7 and Colorectal Carcinogenesis: A Double-Edged SwordEdoardo Troncone, Giovanni Monteleone
Inflammatory Bowel Diseases|September 15, 2017
Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?Massimo C Fantini, Giovanni Monteleone
Pageof 39

Showing results (11-20 of 384) with videos related to

Sort By:
Pageof 39
Inflammatory Bowel Diseases|February 1, 2023
Reply: Frail Phenotype in Patients With Inflammatory Bowel DiseaseSilvia Salvatori, Giovanni Monteleone
Expert Opinion on Drug Safety|June 14, 2017
The safety of non-biological treatments in Ulcerative ColitisEdoardo Troncone, Giovanni Monteleone
United European Gastroenterology Journal|December 29, 2023
Gut microbiota analysis in inflammatory bowel disease: Novel findings from old dataIrene Marafini, Giovanni Monteleone
Annals of Medicine|June 19, 2018
Inflammatory bowel disease: new therapies from antisense oligonucleotidesIrene Marafini, Giovanni Monteleone
Surgical Neurology International|November 19, 2016
Entrapment of the sciatic nerve at the linea aspera: A case report and literature reviewGiovanni Monteleone, Giorgio Stevanato
Inflammatory Bowel Diseases|September 26, 2008
Why are molecular mechanisms of immune activation important in IBD?Giovanni Monteleone, Flavio Caprioli
Expert Review of Gastroenterology & Hepatology|July 20, 2018
Advances in understanding the role of cytokines in inflammatory bowel diseaseGerolamo Bevivino, Giovanni Monteleone
Gastroenterology|August 31, 2015
Reply: To PMID 25785968Giovanni Monteleone, Francesco Pallone
Cancers|May 5, 2019
Smad7 and Colorectal Carcinogenesis: A Double-Edged SwordEdoardo Troncone, Giovanni Monteleone
Inflammatory Bowel Diseases|September 15, 2017
Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?Massimo C Fantini, Giovanni Monteleone
Pageof 39